Biotech RadarJobs updated

COMPANY

BlossomHill Therapeutics

HQ: San Diego, CA source · bhtherapeutics.com ↗

Clinical Phase 2

4 open jobs · last seen Oct 23, 2026 · 3 sources

Profile checked Oct 10, 2026

Keywords: NSCLC (Advanced Non-small Cell Lung Cancer) Leukemia Myeloid Leukemia Leukemia, Myeloid, Acute Preleukemia Myelodysplastic Syndromes Refractory Acute Myeloid Leukemia BH-30643 BH-30236

4Open jobs$84.0MRaised (2 yrs)2Trials (company is sponsor)

Hiring

TitleLocation (from posting)Employer postedFirst seen
Manager, Drug ProductSan Diego, CA, USOct 1, 2026Oct 11, 2026
Director, Regulatory AffairsSan Diego, CA, USSep 3, 2026Oct 11, 2026
Associate Director, Medical WritingCalifornia, San Diego, CA, USSep 3, 2026Oct 11, 2026
Senior Manager, Drug SafetySan Diego, CA, USAug 18, 2026Oct 11, 2026

See all 4 jobs

Timeline

  1. Raise Private placement: $84M (total, as published), announced Dec 10, 2025. Source: company release on GlobeNewswire. source ↗ · Form D filed Dec 10, 2025 SEC Form D ↗
  2. Trial start Phase 1/Phase 2: A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations source ↗
  3. Trial start Phase 1: A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Funding

Raised: $84.0M. Last 2 years.

Clinical trials (lead sponsor) 2

RecordTitlePhaseStatusStartPrimary completion
NCT06706076A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 MutationsPhase 1/Phase 2RecruitingJan 9, 2025Jan 31, 2029 (estimated)
NCT06501196A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic SyndromePhase 1RecruitingJun 19, 20242026-06 (estimated)

Raises and investors new

Form D raises come from the company’s own SEC filing (last 2 years).

Open jobs 4

TitleLocation (from posting, not HQ)Employer postedFirst seenLevel
Manager, Drug ProductSan Diego, CA, USOct 1, 2026Oct 11, 2026Mid
Director, Regulatory AffairsSan Diego, CA, USSep 3, 2026Oct 11, 2026Senior
Associate Director, Medical WritingCalifornia, San Diego, CA, USSep 3, 2026Oct 11, 2026Senior
Senior Manager, Drug SafetySan Diego, CA, USAug 18, 2026Oct 11, 2026Senior

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

Connect

See your connections at BlossomHill Therapeutics on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-04

Feedback